Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)
52,700
-100 (-0.19%)
At close: Feb 9, 2026
HOSE:DBD Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 202,784 | 314,199 | 87,837 | 55,562 | 69,271 |
Short-Term Investments | 409,302 | 124,420 | 221,193 | 221,389 | 139,369 |
Trading Asset Securities | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 |
Cash & Short-Term Investments | 612,087 | 438,620 | 309,032 | 276,953 | 208,641 |
Cash Growth | 39.55% | 41.93% | 11.58% | 32.74% | 3.12% |
Accounts Receivable | 432,220 | 440,459 | 434,102 | 479,867 | 433,329 |
Other Receivables | 8,840 | 5,212 | 3,189 | 5,407 | 4,759 |
Receivables | 441,060 | 445,670 | 437,291 | 485,274 | 438,087 |
Inventory | 366,110 | 505,381 | 487,853 | 450,345 | 255,929 |
Prepaid Expenses | 9,929 | 8,654 | 9,542 | 6,737 | 3,570 |
Other Current Assets | 52,049 | 77,956 | 16,969 | 28,480 | 41,969 |
Total Current Assets | 1,481,235 | 1,476,281 | 1,260,686 | 1,247,789 | 948,197 |
Property, Plant & Equipment | 813,543 | 514,185 | 461,867 | 393,796 | 371,061 |
Long-Term Investments | 150,218 | 164,242 | 163,528 | 154,840 | 140,101 |
Other Intangible Assets | 82,239 | 56,824 | 58,200 | 60,121 | 60,411 |
Long-Term Deferred Tax Assets | 15,760 | 13,292 | 7,969 | 4,593 | 2,885 |
Other Long-Term Assets | 41,102 | 39,383 | 36,659 | 34,579 | 36,863 |
Total Assets | 2,584,097 | 2,264,207 | 1,988,909 | 1,895,717 | 1,559,518 |
Accounts Payable | 219,455 | 160,803 | 125,404 | 163,447 | 102,676 |
Accrued Expenses | 250,624 | 245,279 | 240,456 | 202,548 | 139,379 |
Short-Term Debt | 27,215 | 19,914 | 19,267 | - | 21,029 |
Current Portion of Long-Term Debt | 16,000 | 16,000 | 16,000 | 16,000 | - |
Current Income Taxes Payable | 51,062 | - | - | 14,081 | 12,932 |
Other Current Liabilities | 25,974 | 18,159 | 16,863 | 9,381 | 10,949 |
Total Current Liabilities | 590,330 | 460,155 | 417,989 | 405,457 | 286,966 |
Long-Term Debt | 132,000 | 28,000 | 44,000 | 60,000 | 76,000 |
Other Long-Term Liabilities | 140,561 | 114,911 | 94,078 | 75,123 | 56,003 |
Total Liabilities | 862,891 | 603,066 | 556,068 | 540,580 | 418,969 |
Common Stock | 945,293 | 935,938 | 748,836 | 748,836 | 576,124 |
Additional Paid-In Capital | 20,921 | 20,921 | 20,921 | 20,921 | 20,921 |
Retained Earnings | 759,645 | 699,035 | 652,562 | 574,071 | 539,180 |
Treasury Stock | -1,953 | -1,953 | -1,953 | -1,953 | -1,953 |
Comprehensive Income & Other | -2,701 | 7,198 | 12,475 | 13,262 | 6,276 |
Shareholders' Equity | 1,721,206 | 1,661,141 | 1,432,842 | 1,355,137 | 1,140,549 |
Total Liabilities & Equity | 2,584,097 | 2,264,207 | 1,988,909 | 1,895,717 | 1,559,518 |
Total Debt | 175,215 | 63,914 | 79,267 | 76,000 | 97,029 |
Net Cash (Debt) | 436,872 | 374,706 | 229,765 | 200,953 | 111,612 |
Net Cash Growth | 16.59% | 63.08% | 14.34% | 80.05% | -6.61% |
Net Cash Per Share | 4623.51 | 4005.25 | 2455.96 | 2147.98 | 1193.02 |
Filing Date Shares Outstanding | 94.49 | 93.55 | 93.55 | 93.55 | 93.88 |
Total Common Shares Outstanding | 94.49 | 93.55 | 93.55 | 93.55 | 93.88 |
Working Capital | 890,905 | 1,016,126 | 842,697 | 842,332 | 661,231 |
Book Value Per Share | 18215.89 | 17756.00 | 15315.61 | 14485.03 | 12149.00 |
Tangible Book Value | 1,638,967 | 1,604,317 | 1,374,642 | 1,295,016 | 1,080,138 |
Tangible Book Value Per Share | 17345.54 | 17148.61 | 14693.51 | 13842.40 | 11505.50 |
Buildings | 234,506 | - | - | - | 159,162 |
Machinery | 615,150 | 578,123 | 559,920 | 515,816 | 419,861 |
Construction In Progress | 541,556 | 233,459 | 162,761 | 96,985 | 184,387 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.